Ras superfamily monomeric G proteins in carcinoma cell motility

Cancer Letters

Volumn 189, Issue 2, 2003, Pages 117-128

  Oxford, Gary ^a   Theodorescu, Dan ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Basement membrane; Cdc42; Cell migration; Epithelial cells; Fibroblasts; Rac; Ral; Ras; Rho; Tumorigenesis

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MONOMER; RAS PROTEIN; RHO FACTOR;

CARCINOMA CELL; CELL MIGRATION; CELL MOTILITY; HUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW;

EID: 0037469079     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00510-4     Document Type: Review

References (114)

1. Howe H.L., Wingo P.A., Thun M.J., Ries L.A., Rosenberg H.M., Feigal E.G., Edwards B.K. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl. Cancer Inst. 93:2001;824-842.
2. Su A.I., Welsh J.B., Sapinoso L.M., Kern S.G., Dimitrov P., Lapp H., Schultz P.G., Powell S.M., Moskaluk C.A., Frierson H.F. Jr., Hampton G.M. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res. 61:2001;7388-7393.
3. Fidler I.J. Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg. Oncol. Clin. N. Am. 10:2001;257-269. vii-viiii.
4. Liotta L.A., Kohn E.C. The microenvironment of the tumour-host interface. Nature. 411:2001;375-379.
5. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer. 2:2002;442-454.
6. Cavallaro U., Schaffhauser B., Christofori G. Cadherins and the tumour progression: is it all in a switch? Cancer Lett. 176:2002;123-128.
7. Maulik G., Shrikhande A., Kijima T., Ma P.C., Morrison P.T., Salgia R. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 13:2002;41-59.
8. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:2002;161-174.
9. Jiang Y., Goldberg I.D., Shi Y.E. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene. 21:2002;2245-2252.
10. Frisch S.M., Screaton R.A. Anoikis mechanisms. Curr. Opin. Cell Biol. 13:2001;555-562.
11. Yamada K.M., Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J. Cell Sci. 114:2001;2375-2382.
12. Iwamoto R., Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 11:2000;335-344.
13. Eliceiri B.P. Integrin and growth factor receptor crosstalk. Circ. Res. 89:2001;1104-1110.
14. Wells A. Tumor invasion: role of growth factor-induced cell motility. Adv. Cancer Res. 78:2000;31-101.
15. Stradal T., Courtney K.D., Rottner K., Hahne P., Small J.V., Pendergast A.M. The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia. Curr. Biol. 11:2001;891-895.
16. Hahne P., Sechi A., Benesch S., Small J.V. Scar/WAVE is localised at the tips of protruding lamellipodia in living cells. FEBS Lett. 492:2001;215-220.
17. Horino K., Kindezelskii A.L., Elner V.M., Hughes B.A., Petty H.R. Tumor cell invasion of model 3-dimensional matrices: demonstration of migratory pathways, collagen disruption, and intercellular cooperation. FASEB J. 15:2001;932-939.
18. Gildea J.J., Harding M.A., Gulding K.M., Theodorescu D. Transmembrane motility assay of transiently transfected cells by fluorescent cell counting and luciferase measurement. Biotechniques. 29:2000;81-86.
19. Bloomfield K.L., Baldwin B.L., Harkin D.G., Tonissen K.F. Modification of the Boyden chamber to improve uniformity of cell invasion of matrigel-coated membranes. Biotechniques. 31:2001;1242-1246.
20. Gildea J.J., Harding M.A., Seraj M.J., Gulding K.M., Theodorescu D. The role of Ral A in epidermal growth factor receptor-regulated cell motility. Cancer Res. 62:2002;982-985.
21. Fenteany G., Janmey P.A., Stossel T.P. Signaling pathways and cell mechanics involved in wound closure by epithelial cell sheets. Curr. Biol. 10:2000;831-838.
22. Danninger C., Gimona M. Live dynamics of GFP-calponin: isoform-specific modulation of the actin cytoskeleton and autoregulation by C-terminal sequences. J. Cell Sci. 113:2000;3725-3736.
23. Wells A., Gupta K., Chang P., Swindle S., Glading A., Shiraha H. Epidermal growth factor receptor-mediated motility in fibroblasts. Microsc. Res. Techn. 43:1998;395-411.
24. Lauffenburger D.A., Horwitz A.F. Cell migration: a physically integrated molecular process. Cell. 84:1996;359-369.
25. Feldner J.C., Brandt B.H. Cancer cell motility; on the road from c-erbB-2 receptor steered signaling to actin reorganization. Exp. Cell Res. 272:2002;93-108.
26. Somlyo A.P., Somlyo A.V. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J. Physiol. 522:2000;177-185.
27. Webb D.J., Parsons J.T., Horwitz A.F. Adhesion assembly, disassembly and turnover in migrating cells - Over and over and over again. Nat. Cell Biol. 4:2002;E97-E100.
28. Glading A., Lauffenburger D.A., Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol. 12:2002;46-54.
29. Turner C.E., Brown M.C. Cell motility: ARNOand ARF6 at the cutting edge. Curr. Biol. 11:2001;R875-R877.
30. Mercurio A.M., Rabinovitz I., Shaw L.M. The alpha 6 beta 4 integrin and epithelial cell migration. Curr. Opin. Cell Biol. 13:2001;541-545.
31. Malumbres M., Pellicer A. Ras pathways to cell cycle control and cell transformation. Front. Biosci. 3:1998;d887-d912.
32. Reuther G.W., Der C.J. The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr. Opin. Cell Biol. 12:2000;157-165.
33. Pruitt K., Der C.J. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett. 171:2001;1-10.
34. Sahai E., Marshall C.J. Rho-GTPases and cancer. Nat. Rev. Cancer. 2:2002;133-142.
35. Donaldson J.G., Jackson C.L. Regulators and effectors of the ARF GTPases. Curr. Opin. Cell Biol. 12:2000;475-482.
36. Pfeffer S.R. Rab GTPases: specifying and deciphering organelle identity and function. Trends Cell Biol. 11:2001;487-491.
37. Kuersten S., Ohno M., Mattaj I.W. Nucleocytoplasmic transport: ran, beta and beyond. Trends Cell Biol. 11:2001;497-503.
38. Donovan S., Shannon K.M., Bollag G. GTPase activating proteins: critical regulators of intracellular signaling. Biochim. Biophys. Acta. 1602:2002;23-45.
39. Cherfils J., Chardin P. GEFs: structural basis for their activation of small GTP-binding proteins. Trends Biochem. Sci. 24:1999;306-311.
40. Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cellular Signalling. 11:1999;545-554.
41. Yamada M., Tachibana T., Imamoto N., Yoneda Y. Nuclear transport factor p10/NTF2 functions as a Ran-GDP dissociation inhibitor (Ran-GDI). Curr. Biol. 8:1998;1339-1342.
42. Wu S.K., Zeng K., Wilson I.A., Balch W.E. Structural insights into the function of the Rab GDI superfamily. Trends Biochem. Sci. 21:1996;472-476.
43. Zhang C., Clarke P.R. Roles of Ran-GTP and Ran-GDP in precursor vesicle recruitment and fusion during nuclear envelope assembly in a human cell-free system. Curr. Biol. 11:2001;208-212.
44. Di-Poi N., Faure J., Grizot S., Molnar G., Pick E., Dagher M.C. Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex. Biochemistry. 40:2001;10014-10022.
45. Lowy D.R., Willumsen B.M. Function and regulation of ras. Annu. Rev. Biochem. 62:1993;851-891.
46. Lin R., Bagrodia S., Cerione R., Manor D., novel A. Cdc42Hs mutant induces cellular transformation. Curr. Biol. 7:1997;794-797.
47. Reinstein J., Schlichting I., Frech M., Goody R.S., Wittinghofer A. p21 with a phenylalanine 28; leucine mutation reacts normally with the GTPase activating protein GAP but nevertheless has transforming properties. J. Biol. Chem. 266:1991;17700-17706.
48. Feig L.A. Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases. Nat. Cell Biol. 1:1999;E25-E27.
49. Brummelkamp T.R., Bernards R., Agami R., system A. for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
50. Yu J.Y., DeRuiter S.L., Turner D.L., interference R.N.A. by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA. 99:2002;6047-6052.
51. Prendergast G.C. Actin' up: RhoB in cancer and apoptosis. Nat. Rev. Cancer. 1:2001;162-168.
52. Lerm M., Schmidt G., Aktories K. Bacterial protein toxins targeting rho GTPases. FEMS Microbiol. Lett. 188:2000;1-6.
53. Jackson C.L., Casanova J.E. Turning on ARF: the Sec7 family of guanine-nucleotide-exchange factors. Trends Cell Biol. 10:2000;60-67.
54. Abraham M.T., Kuriakose M.A., Sacks P.G., Yee H., Chiriboga L., Bearer E.L., Delacure M.D. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope. 111:2001;1285-1289.
55. Fritz G., Just I., Kaina B. Rho GTPases are over-expressed in human tumors. Int. J. Cancer. 81:1999;682-687.
56. Kleer C.G., van Golen K.L., Zhang Y., Wu Z.F., Rubin M.A., Merajver S.D. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am. J. Pathol. 160:2002;579-584.
57. Suwa H., Ohshio G., Imamura T., Watanabe G., Arii S., Imamura M., Narumiya S., Hiai H., Fukumoto M. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br. J. Cancer. 77:1998;147-152.
58. Schnelzer A., Prechtel D., Knaus U., Dehne K., Gerhard M., Graeff H., Harbeck N., Schmitt M., Lengyel E. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene. 19:2000;3013-3020.
59. Jordan P., Brazao R., Boavida M.G., Gespach C., Chastre E. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene. 18:1999;6835-6839.
60. Schwartz M.A., Toksoz D., Khosravi-Far R. Transformation by Rho exchange factor oncogenes is mediated by activation of an integrin-dependent pathway. EMBO J. 15:1996;6525-6530.
61. Bustelo X.R. The VAV family of signal transduction molecules. Crit. Rev. Oncogen. 7:1996;65-88.
62. Wang D.Z., Nur E.K.M.S., Tikoo A., Montague W., Maruta H. The GTPase and Rho GAP domains of p190, a tumor suppressor protein that binds the M(r) 120,000 Ras GAP, independently function as anti-Ras tumor suppressors. Cancer Res. 57:1997;2478-2484.
63. Seraj M.J., Harding M.A., Gildea J.J., Welch D.R., Theodorescu D. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin. Exp. Metastasis. 18:2000;519-525.
64. Kaibuchi K., Kuroda S., Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu. Rev. Biochem. 68:1999;459-486.
65. Amano M., Fukata Y., Kaibuchi K. Regulation and functions of Rho-associated kinase. Exp. Cell Res. 261:2000;44-51.
66. Watanabe N., Kato T., Fujita A., Ishizaki T., Narumiya S. Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat. Cell Biol. 1:1999;136-143.
67. Nakano K., Takaishi K., Kodama A., Mammoto A., Shiozaki H., Monden M., Takai Y. Distinct actions and cooperative roles of ROCK and mDia in Rho small G protein-induced reorganization of the actin cytoskeleton in Madin-Darby canine kidney cells. Mol. Biol. Cell. 10:1999;2481-2491.
68. Tsuji T., Ishizaki T., Okamoto M., Higashida C., Kimura K., Furuyashiki T., Arakawa Y., Birge R.B., Nakamoto T., Hirai H., Narumiya S. ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts. J. Cell Biol. 157:2002;819-830.
69. O'Connor K.L., Nguyen B.K., Mercurio A.M. RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism. J. Cell Biol. 148:2000;253-258.
70. Jo M., Thomas K.S., Somlyo A.V., Somlyo A.P., Gonias S.L. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration. J. Biol. Chem. 277:2002;12479-12485.
71. Kusama T., Mukai M., Iwasaki T., Tatsuta M., Matsumoto Y., Akedo H., Nakamura H. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. Cancer Res. 61:2001;4885-4891.
72. Yoshioka K., Nakamori S., Itoh K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res. 59:1999;2004-2010.
73. Tsubakimoto K., Matsumoto K., Abe H., Ishii J., Amano M., Kaibuchi K., Endo T. Small GTPase RhoD suppresses cell migration and cytokinesis. Oncogene. 18:1999;2431-2440.
74. Guasch R.M., Scambler P., Jones G.E., Ridley A.J. RhoE regulates actin cytoskeleton organization and cell migration. Mol. Cell. Biol. 18:1998;4761-4771.
75. Somlyo A.V., Bradshaw D., Ramos S., Murphy C., Myers C.E., Somlyo A.P. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem. Biophys. Res. Commun. 269:2000;652-659.
76. Kaneko K., Satoh K., Masamune A., Satoh A., Shimosegawa T. Expression of ROCK-1 in human pancreatic cancer: its down-regulation by morpholino oligo antisense can reduce the migration of pancreatic cancer cells in vitro. Pancreas. 24:2002;251-257.
77. Bourguignon L.Y., Zhu H., Shao L., Zhu D., Chen Y.W. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motility Cytoskeleton. 43:1999;269-287.
78. Clark E.A., Golub T.R., Lander E.S., Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 406:2000;532-535.
79. van Golen K.L., Wu Z.F., Qiao X.T., Bao L.W., Merajver S.D. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res. 60:2000;5832-5838.
80. van Golen K.L., Bao L.W., Pan Q., Miller F.R., Wu Z.F., Merajver S.D. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin. Exp. Metastasis. 19:2002;301-311.
81. Schmitz A.A., Govek E.E., Bottner B., Van Aelst L. Rho GTPases: signaling, migration, and invasion. Exp. Cell Res. 261:2000;1-12.
82. Ridley A.J. Rho GTPases and cell migration. J. Cell Sci. 114:2001;2713-2722.
83. Rottner K., Hall A., Small J.V. Interplay between Rac and Rho in the control of substrate contact dynamics. Curr. Biol. 9:1999;640-648.
84. Kuroda S., Fukata M., Kobayashi K., Nakafuku M., Nomura N., Iwamatsu A., Kaibuchi K. Identification of IQGAP as a putative target for the small GTPasesCdc42 and Rac1. J. Biol. Chem. 271:1996;23363-23367.
85. Matozaki T., Nakanishi H., Takai Y. Small G-protein networks: their crosstalk and signal cascades. Cellular Signalling. 12:2000;515-524.
86. O'Connor K.L., Mercurio A.M. Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells. J. Biol. Chem. 276:2001;47895-47900.
87. Wei Q., Adelstein R.S. Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling. Mol. Biol. Cell. 13:2002;683-697.
88. Engers R., Springer E., Michiels F., Collard J.G., Gabbert H.E. Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. J. Biol. Chem. 276:2001;41889-41897.
89. Adjei A.A. Blocking oncogenic Ras signaling for cancer therapy. J. Natl. Cancer Inst. 93:2001;1062-1074.
90. Field J.K., Spandidos D.A. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review). Anticancer Res. 10:1990;1-22.
91. Vageli D., Kiaris H., Delakas D., Anezinis P., Cranidis A., Spandidos D.A. Transcriptional activation of H-rasK-ras and N-ras proto-oncogenes in human bladder tumors. Cancer Lett. 107:1996;241-247.
92. Shivakumar L., Minna J., Sakamaki T., Pestell R., White M.A. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell. Biol. 22:2002;4309-4318.
93. Cichowski K., Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell. 104:2001;593-604.
94. Bar-Sagi D., Hall A. Ras and Rho GTPases: a family reunion. Cell. 103:2000;227-238.
95. Walsh A.B., Bar-Sagi D. Differential activation of the Rac pathway by Ha-Ras and K-Ras. J. Biol. Chem. 276:2001;15609-15615.
96. Klemke R.L., Cai S., Giannini A.L., Gallagher P.J., de Lanerolle P., Cheresh D.A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137:1997;481-492.
97. Glading A., Chang P., Lauffenburger D.A., Wells A. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J. Biol. Chem. 275:2000;2390-2398.
98. Keely P.J., Rusyn E.V., Cox A.D., Parise L.V. R-Ras signals through specific integrin alpha cytoplasmic domains to promote migration and invasion of breast epithelial cells. J. Cell Biol. 145:1999;1077-1088.
99. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., Der C.J. Increasing complexity of Ras signaling. Oncogene. 17:1998;1395-1413.
100. Ueoka Y., Kato K., Kuriaki Y., Horiuchi S., Terao Y., Nishida J., Ueno H., Wake N. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway. Br. J. Cancer. 82:2000;891-899.
101. Nguyen D.H., Catling A.D., Webb D.J., Sankovic M., Walker L.A., Somlyo A.V., Weber M.J., Gonias S.L. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J. Cell Biol. 146:1999;149-164.
102. Kainuma O., Asano T., Hasegawa M., Kenmochi T., Nakagohri T., Tokoro Y., Isono K. Inhibition of growth and invasive activity of human pancreatic cancer cells by a farnesyltransferase inhibitor, manumycin. Pancreas. 15:1997;379-383.
103. Jullien-Flores V., Dorseuil O., Romero F., Letourneur F., Saragosti S., Berger R., Tavitian A., Gacon G., Camonis J.H. Bridging Ral GTPase to Rho pathwaysRLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J. Biol. Chem. 270:1995;22473-22477.
104. Ohta Y., Suzuki N., Nakamura S., Hartwig J.H., Stossel T.P. The small GTPase RalA targets filamin to induce filopodia. Proc. Natl, Acad. Sci. USA. 96:1999;2122-2128.
105. Ward Y., Wang W., Woodhouse E., Linnoila I., Liotta L., Kelly K. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol. Cell. Biol. 21:2001;5958-5969.
106. Cockcroft S. Signalling roles of mammalian phospholipase D1 and D2. Cellul. Mol. Life Sci. 58:2001;1674-1687.
107. Moskalenko S., Henry D.O., Rosse C., Mirey G., Camonis J.H., White M.A. The exocyst is a Ral effector complex. Nat. Cell Biol. 4:2002;66-72.
108. Shen Y., Xu L., Foster D.A. Role for phospholipase D in receptor-mediated endocytosis. Mol. Cell. Biol. 21:2001;595-602.
109. Santy L.C., Casanova J.E. Activation of ARF6 by ARNO stimulates epithelial cell migration through downstream activation of both Rac1 and phospholipase D. J. Cell Biol. 154:2001;599-610.
110. Palacios F., Price L., Schweitzer J., Collard J.G., D'Souza-Schorey C. An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J. 20:2001;4973-4986.
111. Novick P., Guo W. Ras family therapy: Rab Rho and Ral talk to the exocyst. Trends Cell Biol. 12:2002;247-249.
112. Imamura H., Takaishi K., Nakano K., Kodama A., Oishi H., Shiozaki H., Monden M., Sasaki T., Takai Y. Rho and Rab small G proteins coordinately reorganize stress fibers and focal adhesions in MDCK cells. Mol. Biol. Cell. 9:1998;2561-2575.
113. Truong K., Ikura M. The use of FRET imaging microscopy to detect protein-protein interactions and protein conformational changes in vivo. Curr. Opin. Struct. Biol. 11:2001;573-578.
114. Mercurio A.M., Rabinovitz I. Towards a mechanistic understanding of tumor invasion-lessons from the alpha6beta 4 integrin. Semin. Biol. 11:2001;129-141.